Suppr超能文献

仔猪在 1 周龄时接种灭活支原体肺炎疫苗可减少肺部病变并提高平均日增重。

Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight.

机构信息

Pfizer Animal Health, Veterinary Medicine Research and Development, Hoge Wei 10, 1930 Zaventem, Belgium.

出版信息

Vaccine. 2012 Dec 14;30(52):7625-9. doi: 10.1016/j.vaccine.2012.10.028. Epub 2012 Oct 19.

Abstract

The field efficacy and safety of a single-dose inactivated Mycoplasma hyopneumoniae vaccine, Suvaxyn MH-One, was evaluated in 4-5-day-old piglets on a commercial farm with a history of Mycoplasma disease in Southern Germany. The piglets were injected intramuscularly with the vaccine or saline (control group) and raised under commercial conditions to slaughter weight. The efficacy of the vaccine was determined by comparing the lung lesions associated with infection by M. hyopneumoniae in control and vaccinated pigs post mortem. In this analysis the vaccinated pigs had the lower mean percentage lung lesion at 5% compared to 9% in controls. Of the vaccinated pigs 52.3% were shown to have low levels of lung lesions between 0% and 5% and no more than 5.4% were shown to have levels above 20%. In contrast, the pigs administered saline showed 36.5% in the lower category (0-5%), while 18.3% showed lesions greater than 20%. There were significant differences in the mean body weight of pigs at the final two weight measurements at approximately 21 weeks and 26 weeks of age, with those receiving Suvaxyn MH-One being on average 5 kg heavier at each time point. There was also a significant increase in average daily gain in the vaccinated animals compared to the control group, particularly in the period from vaccination to the final two body weight measurements on day 138 and 166, from weaning at day 28 to the final two body measurements and from mid-way during finishing at day 84 to the final two body weight measurements. Vaccination had no adverse impact on appetite, although small numbers of vaccinated and control pigs did show mild signs of coughing, sneezing, respiratory distress or depression. There was no adverse impact on rectal temperatures and no signs of injection site reactions during the course of the study. We can conclude that vaccination with Suvaxyn MH-One to pigs at less than 1 week of age is effective in reducing lung lesions resulting from M. hyopneumoniae and also aids growth performance by reducing weight losses and improving average daily gain.

摘要

在德国南部的一个有支原体病史的商业农场,对 4-5 日龄的仔猪进行了单剂量灭活支原体肺炎疫苗 Suvaxyn MH-One 的田间功效和安全性评估。仔猪肌肉注射疫苗或生理盐水(对照组),并在商业条件下饲养至屠宰体重。通过比较死后感染支原体肺炎的对照组和接种疫苗的仔猪的肺病变,来确定疫苗的功效。在这项分析中,接种疫苗的仔猪的平均肺病变百分比为 5%,而对照组为 9%。接种疫苗的仔猪中,有 52.3%的肺病变程度较低,在 0%-5%之间,且不超过 5.4%的仔猪肺病变程度超过 20%。相比之下,接受生理盐水治疗的仔猪中有 36.5%处于较低类别(0-5%),而 18.3%的仔猪肺病变程度大于 20%。在大约 21 周和 26 周龄的最后两次体重测量时,接种疫苗和未接种疫苗的仔猪的平均体重存在显著差异,接种 Suvaxyn MH-One 的仔猪每次体重平均增加 5 公斤。与对照组相比,接种疫苗的动物的平均日增重也显著增加,特别是在从接种到第 138 天和 166 天的最后两次体重测量、从 28 天断奶到最后两次体重测量以及从 84 天育肥中期到最后两次体重测量的时期。疫苗接种对食欲没有不利影响,尽管少数接种疫苗和对照组的仔猪确实表现出轻微的咳嗽、打喷嚏、呼吸困难或抑郁迹象。在研究过程中,直肠温度没有受到影响,也没有发现注射部位反应的迹象。我们可以得出结论,对 1 周龄以下的仔猪进行 Suvaxyn MH-One 疫苗接种,可有效降低支原体肺炎引起的肺病变,并通过减少体重损失和提高平均日增重来改善生长性能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验